Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia (COES)

This study has been completed.
Sponsor:
Collaborators:
Dartmouth-Hitchcock Medical Center
Commonwealth Research Center, Massachusetts
Eli Lilly and Company
Information provided by (Responsible Party):
AlanGreen, National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00169065
First received: September 10, 2005
Last updated: April 6, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2002
  Primary Completion Date: June 2002 (Final data collection date for primary outcome measure)